# P3 Study Comparing Once Daily SB204 and Vehicle Gel in Acne

> **NCT02667444** · PHASE3 · COMPLETED · sponsor: **Novan, Inc.** · enrollment: 1330 (actual)

## Conditions studied

- Acne Vulgaris

## Interventions

- **DRUG:** SB204 4%
- **DRUG:** Vehicle Gel

## Key facts

- **NCT ID:** NCT02667444
- **Lead sponsor:** Novan, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-02-19
- **Primary completion:** 2016-12
- **Final completion:** 2016-12-09
- **Target enrollment:** 1330 (ACTUAL)
- **Last updated:** 2023-07-24

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02667444

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02667444, "P3 Study Comparing Once Daily SB204 and Vehicle Gel in Acne". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02667444. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*